Discuss the future of biosimilars and formulate solutions to the complex regulatory and patent challenges ahead with industry leaders from both innovator and biosimilar companies

Network with leading counsel representing both biosimilar and innovator companies at the industry’s one and only event directed to the legal, regulatory, and commercial aspects of the biosimilars marketplace.

ACI is proud to present a stellar speaking faculty consisting of top innovator and biosimilar makers, government representatives, and leading law firms as they discuss the hottest industry challenges and provide their skilled insights into the design and execution of successful biosimilars strategies.

Full conference details are on the way shortly – stay up-to-date by signing up to receive emails.

Hear what past participants have to say about this one-of-a-kind event:

  • “Catching up on a year of changes to the biosimilar space in 2 days.”
  • “Enjoyed attending the seminar presentations, knowledge base of speakers was tremendous.”
  • “Very good speakers and good selected topics. I especially like to see the panels on FDA and economic topics, as these are important, but less frequently addressed.”
  • “Very good and informative. Excellent experience.”
  • “One of the best CLEs I’ve been to in 10 years.”

Don’t miss your opportunity to save with Early Bird rates!

Register now and be part of the prestigious meeting of the minds.

stay up-to-date by signing up for email updates.

Event Contacts

For sponsorship opportunities please contact:
Wendy Tyler
Tel: 212-352-3220 ext. 5242
[email protected]

For media partnership opportunities please contact:
Andrea Sachs
Tel: 212-352-3220 ext. 5224
[email protected]

For questions about this year’s program/content, or information on how you can speak next year please contact:
Lisa Piccolo
Tel: 212-352-3220 ext. 5229
[email protected]